Moxifloxacin-associated neutropenia

Abstract A 32-y-old woman presented with pneumonia. Treatment was started with moxifloxacin. On day 2 of moxifloxacin treatment the patient developed neutropenia. After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adver...

Full description

Saved in:
Bibliographic Details
Published inScandinavian journal of infectious diseases Vol. 45; no. 5; pp. 415 - 416
Main Authors Berk, Veli, Demiraslan, Hayati, Berk, Elife, Karaca, Halit, Inanc, Mevlude, Bozkurt, Oktay, Ozkan, Metin
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.05.2013
Subjects
Adult
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - therapeutic use
Aza Compounds - adverse effects
Aza Compounds - therapeutic use
Female
Fluoroquinolones
Humans
Leukocyte Count
Neutropenia - chemically induced
Pneumonia - blood
Pneumonia - drug therapy
Quinolines - adverse effects
Quinolines - therapeutic use
Online AccessGet full text

Cover

More Information
Summary:Abstract A 32-y-old woman presented with pneumonia. Treatment was started with moxifloxacin. On day 2 of moxifloxacin treatment the patient developed neutropenia. After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0036-5548
1651-1980
DOI:10.3109/00365548.2012.738937